Previous Article | Next Article 
Journal of Clinical Microbiology, April 2000, p. 1684-1687, Vol. 38, No. 4
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Selective Isolation of eae-Positive
Strains of Shiga Toxin-Producing Escherichia
coli
Hiroshi
Fukushima,*
Ken
Hoshina, and
Manabu
Gomyoda
Public Health Institute of Shimane
Prefecture, Matsue, Shimane 690-0122, Japan
Received 21 September 1999/Returned for modification 28 September
1999/Accepted 15 January 2000
 |
ABSTRACT |
Culture on cefixime, tellurite, and sorbitol-MacConkey agar after
HCl treatment facilitated the growth of 410 (94%) of 436 eae-positive Shiga toxin-producing Escherichia
coli (STEC) strains and 17 (16%) of 107 eae-negative
STEC strains. This selectivity was closely related to acid resistance
in E. coli and tellurite resistance in
eae-positive STEC strains.
 |
TEXT |
Shiga toxin-producing
Escherichia coli (STEC) strains of different serotypes have
been increasingly isolated from humans with disease and from healthy
domestic animals (3, 6-8, 10, 11, 13, 17). Many of these
isolates were typical STEC strains belonging to serotypes O26:H11,
O103:H2, O111:H
, O113:H21, H145:H
, and O157:H7, which in humans can
cause severe disease, such as hemorrhagic colitis (HC) and
hemolytic-uremic syndrome (HUS) (11, 17). Numerous other
serotypes of STEC either are associated with disease at low frequency
or have not been implicated in disease (2, 10). Various
virulence factors have been identified in STEC (12, 15, 19).
Shiga toxins (Stx1 and Stx2) encoded by the stx1
and stx2 genes may contribute to the occurrence
of diarrhea (15) and appear to be necessary for HC and HUS
(9). Some STEC strains can tightly attach to epithelial
cells of the intestine through an adhesin called intimin
(2), which is encoded by the eae gene of
attaching and effacing lesions (12). Almost all STEC strains
produce an enterohemorrhagic E. coli-specific plasmid-encoded hemolysin, encoded by hlyA (19).
However, only eae and stx2 were
significantly associated with isolates from serotypes found in humans
or with isolates from serotypes implicated in severe human disease
(2).
While various approaches have been used to develop isolation and
detection procedures for STEC O157 (3, 8), effective isolation and detection of serotypes of STEC other than O157:H7 have
apparently not been reported. Our group (6, 7) reported an
effective, rapid, and simple method for isolation of STEC O26, O111,
and O157 from feces and food samples, namely by culture on cefixime
(0.05 mg/liter), tellurite (2.5 mg/liter), and sorbitol-MacConkey agar
(CT-SMAC) (24) after hydrochloric acid treatment of samples, as well as enrichment cultures. This new method is based on the acid
resistance of E. coli and the tellurite resistance of STEC O26, O111, and O157. One purpose of the present study was to determine if the culture on CT-SMAC after acid treatment is a useful method not
only for isolating STEC O26, O111, and O157, but also for isolating
other serotypes which can cause severe disease in humans. We also
examined the relationship between tellurite resistance and virulence
factors of STEC.
A total of 543 STEC strains, an enteroinvasive E. coli
(EIEC) strain, two enterotoxigenic E. coli (ETEC) strains,
and 18 enteropathogenic E. coli (EPEC) strains were
collected from researchers in Japan and Germany and isolated in our
laboratory (Table 1). The isolates were
separated into three groups according to the grouping by Gyles et al.
(10). Group 1 consisted of 321 human isolates and 92 bovine
isolates, one food isolate, and 4 environmental isolates belonging to 8 serotypes which occur at moderate to high frequencies in severe human
disease. In Japan, O121:H19 strains were isolated from sporadic cases
of severe human disease and were classified into group 1. Group 2 consisted of 47 human isolates belonging to serotypes less frequently
implicated in human disease. Group 3 consisted of 58 bovine isolates,
two ovine isolates, 5 beef isolates, and 13 environmental isolates
belonging to serotypes that have not been implicated in human disease.
The importance of gastric juice in controlling the outcome of
food-borne infections is well recognized. To cause human illness, an
invading organism must survive the acidic environment of the stomach
before the organism reaches the intestine. Thus, acidity of gastric
juice provides a first line of defense against food-borne pathogens
(1). We reported that HCl treatment is effective for the
separation of E. coli from other gram-negative bacteria, but
the data covered only 17 strains (6). To confirm the effects of acid resistance in E. coli, bacterial suspensions of
107 to 109 CFU/ml (50 µl), cultured in
Trypticase soy broth (BBL, Cockeysville, Md.) at 37°C for 18 h,
were transferred to 0.125 N HCl-0.5% NaCl solutions (50 µl), mixed,
and held for 30 s. Then 20-µl portions of each HCl-treated
suspension were put into 1 ml of 0.067 M phosphate-buffered saline (pH
7.2), after which, a 100-fold dilution (10 µl) of those suspensions
was placed on Trypticase soy agar (BBL) and then cultured at 37°C for
18 h. The viable count for all strains of E. coli decreased from 0 to 1 log10 after exposure to 0.125 N HCl
for 30 s, regardless of differences in serotypes and
pathogenicity. Therefore, E. coli, including STEC, has
resistance to HCl.
Although the mechanism of tellurite resistance in pathogens, including
Corynebacterium diphtheriae, Staphylococcus
aureus, Vibrio cholerae, and Shigella spp.,
is unknown, tellurite has been used to isolate these bacteria (14,
21). Thereafter, tellurite was used for selection of STEC O26,
O111, and O157 from other members of the E. coli family
(6, 7, 24). Data on growth of STEC, EPEC, EIEC, and ETEC on
CT-SMAC are given in Table 1. A 100-fold dilution (10 µl) of
bacterial suspensions of 107 to 109 CFU/ml was
cultured on SMAC and CT-SMAC at 37°C for 18 h. O157 strains
showed sorbitol-nonfermenting colonies, while other serotypes showed
sorbitol-fermenting colonies, except for five strains: O78:H21,
O103:H2, O121:H19, O145:H
, and O121:H19 on CT-SMAC. Of 418 group 1 isolates, 402 grew on CT-SMAC, with no significant reduction in the
size or number of colonies. However, 32 of 47 group 2 isolates, 69 of
78 group 3 isolates, and 18 of 20 other pathogenic E. coli
isolates showed inhibited growth on CT-SMAC. The MICs of potassium
tellurite (Daigo, Japan) for STEC are given in Table
2. A range of dilutions of tellurite were
prepared in 20-ml volumes in a petri dish with Mueller-Hinton II agar
(BBL). Ten microliters of cultures was placed on plates with each
dilution of tellurite (final concentrations, 400 to 0.05 mg/liter), and the plates were incubated at 37°C for 18 h. The lowest dilution of tellurite that inhibited growth was recorded as the MIC. At a
tellurite concentration of 3.1 mg/liter, which is near and over the
concentration (2.5 mg/liter) inoculated in CT-SMAC, 402 group 1 isolates grew. To determine the MICs for 36 group 2 isolates, 63 group
3 isolates, and 16 other E. coli isolates, the tellurite concentration was under 3.1 mg/liter. The frequency of growth on
CT-SMAC was significantly higher in group 1 isolates than in group 2 and 3 isolates (P < 0.01, respectively). Thus,
selective isolation of group 1 isolates such as O26:H11, O111:H
, and
O157:H7, and also of O26:H
, O103:H2, O121:H19, O145:H
, and
O157:H
, was feasible by culture on CT-SMAC.
The eae, stx2, and hlyA
genes are found more frequently in STEC isolates from patients with
severe disease than in other STEC populations (16, 18, 20),
and the stx1 gene may be associated with some
STEC isolates of bovine origin (13). The association of four
virulence-related genes with tellurite resistance was examined by
multiplex PCR and growth on CT-SMAC of STEC isolates (Tables 1 and
3). Multiplex PCR amplification was used
to detect the stx1, stx2,
eae, and hlyA genes in all 543 STEC isolates and EIEC, ETEC, and EPEC isolates. The multiplex PCR amplification protocols used were those described by Fagan et al. (4). The primers used were those described by Gannon et al. (8) for stx1, stx2, and
eae and by Fratamico et al. (5) for
hlyA. The stx1 and
stx2 genes were present in 79 and 57%, 65 and
67%, and 47 and 75% of the STEC isolates belonging to groups 1, 2, and 3, respectively. The stx1 gene was more
frequently detected in isolates of group 1 than in the isolates of
groups 2 and 3 (0.05 > P > 0.01 and P < 0.01, respectively). In group 1, isolates belonging to
serotypes O26:H11, O26:H
, O103:H2, and O111:H
were predominantly positive for stx1 and isolates belonging to
serotypes O121:H19, O157:H7, and O157:H
were predominantly positive
for stx2. Two-thirds of O157:H7 and O157:H
were positive for both stx1 and
stx2. O145:H
isolates had either the
stx1 gene or the stx2
gene, but not both (Table 1). There was a slight difference
(0.05 > P > 0.01) between growth on CT-SMAC and
the presence of stx genes, because growth on CT-SMAC was
observed in 83 and 76% of isolates with the
stx1 and stx2 genes,
respectively (Table 3). Thus, there was no close relationship between
stx1 and stx2 and
tellurite resistance in STEC.
The prevalence (99%) of eae in group 1 was significantly
higher than the low prevalence (33 or 7.7%, respectively) of this gene
in group 2 or 3 (P < 0.001, respectively). There was a
significant difference (P < 0.001) between growth on
CT-SMAC and the presence of eae. Growth on CT-SMAC was
observed in 94% of the eae-positive isolates and in 16% of
the eae-negative isolates (Table 3). The frequencies of
occurrence of the hlyA gene in group 1, 2, and 3 isolates
were 98, 65, and 82%, respectively (Table 1). The prevalence of
hlyA in group 1 and 3 isolates was significantly higher than
the prevalence of this gene in group 2 isolates (P < 0.01 and 0.05 > P > 0.01, respectively).
There was a significant difference (P < 0.01) between
growth on CT-SMAC and the presence of the hlyA gene. Growth
on CT-SMAC was observed in 82% of the hlyA-positive
isolates and 38% of the hlyA-negative isolates (Table 3).
Although these data suggest an association of hlyA with
tellurite resistance, there was no significant difference (P < 0.05) between growth on CT-SMAC and the presence of the
hlyA gene in the eae-negative and
eae-positive isolates (Table 3). These findings show
significant differences between growth on CT-SMAC and the presence of
the eae gene, but not the stx1,
stx2, and hlyA genes. This close
relationship between the presence of the eae gene in
isolates and tellurite resistance of isolates showed that culture on
CT-SMAC after HCl treatment facilitated isolation of
eae-positive strains of STEC, such as group 1 isolates
belonging to serotypes O26:H11, O26:H
, O103:H2, O111:H
, O121:H19,
O145:H
, O157:H7, and O157:H
, associated with severe disease in
humans. Because some strains (6%) of eae-positive STEC did
not grow on CT-SMAC, selective media without tellurite should also be
used for routine isolations of STEC.
The mechanism of tellurite resistance in STEC O157 is unknown, and
whether it is chromosomally or plasmid mediated is also unclear
(24). Although intrinsic tellurite resistance in members of
the family Enterobacteriaceae is often plasmid mediated
(23), it has been reported that chromosomally mediated
resistance can be induced in tellurite-sensitive strains of E. coli, and possible mechanisms of resistance include reduced uptake
via the phosphate transport pathway and reduction to metallic tellurium
(22). In the present study, there was a significant
difference between tellurite resistance and the presence of the
eae gene encoded by chromosome, but not the presence of the
hlyA gene encoded by plasmid. These findings suggest the
possibility that tellurite resistance of STEC may be encoded by a gene
close to or near lesions containing the eae gene on the chromosome.
 |
ACKNOWLEDGMENTS |
We thank S. Aleksic, H. Watanabe, T. Takeda, T. Horii, K. Takesi,
R. Tsutsui, J. Yatsuyanagi, K. Otani, M. Kumagai, A. Hirose, N. Hiruta,
N. Agata, K. Sugiyama, K. Ishikawa, T. Morigaki, K. Shimada, M. Kuroda,
T. Ashiya, M. Sakaki, M. Tomita, H. Nakajima, H. Morihara, C. Sunahara,
T. Shimizu, T. Yasuoka, K. Ogata, S. Moroishi, K. Kawano, and S. Kushima for providing STEC strains for our collection. We are also
indebted to H. Watanabe and K. Tamura for serotyping the strains.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Public Health
Institute of Shimane Prefecture, 582-1 Nishihamasada, Matsue,
Shimane 690-0122, Japan. Phone: 0852-36-8181. Fax: 0852-36-6683. E-mail: hiroshi{at}joho-shimane.or.jp.
 |
REFERENCES |
| 1.
|
Benjamin, M. M., and A. R. Datta.
1995.
Acid tolerance of enterohemorrhagic Escherichia coli.
Appl. Environ. Microbiol.
61:1669-1672[Abstract].
|
| 2.
|
Boerlin, P.,
S. A. McEwen,
F. Boerlin-Petzold,
J. B. Wilson,
R. P. Johnson, and C. L. Gyles.
1999.
Association between virulence factors of Shiga toxin-producing Escherichia coli and disease in humans.
J. Clin. Microbiol.
37:497-503[Abstract/Free Full Text].
|
| 3.
|
Chapman, P. A.,
A. T. Cerdan Malo,
C. A. Siddons, and M. Harkin.
1997.
Use of commercial enzyme immunoassays and immunomagnetic separation systems for detecting Escherichia coli O157 in bovine fecal samples.
Appl. Environ. Microbiol.
63:2549-2553[Abstract].
|
| 4.
|
Fagan, P. T.,
M. A. Hornitzky,
K. A. Bettelheim, and S. P. Djordjevic.
1999.
Detection of Shiga-like toxin (stx1 and stx2), intimin (eaeA), and enterohemorrhagic Escherichia coli (EHEC) hemolysin (EHEC hlyA) genes in animal feces by multiplex PCR.
Appl. Environ. Microbiol.
65:868-872[Abstract/Free Full Text].
|
| 5.
|
Fratamico, P. M.,
S. K. Sackitey,
M. Wiedmann, and M. Y. Deng.
1995.
Detection of Escherichia coli O157:H7 by multiplex PCR.
J. Clin. Microbiol.
33:2188-2191[Abstract].
|
| 6.
|
Fukushima, H., and M. Gomyoda.
1999.
Hydrochloric acid treatment for rapid recovery of Shiga toxin-producing Escherichia coli O26, O111 and O157 from faeces, food and environmental samples.
Zentbl. Bakteriol.
289:285-299.
|
| 7.
|
Fukushima, H., and M. Gomyoda.
1999.
An effective, rapid and simple method for isolation of Shiga toxin-producing Escherichia coli O26, O111 and O157 from feces and food samples.
Zentbl. Bakteriol.
289:415-428.
|
| 8.
|
Gannon, V. P. J.,
R. K. King,
J. Y. Kim, and E. J. Golsteyn Thomas.
1992.
Rapid and sensitive method for detection of Shiga-like toxin-producing Escherichia coli in ground beef using the polymerase chain reaction.
Appl. Environ. Microbiol.
58:3809-3815[Abstract/Free Full Text].
|
| 9.
|
Griffin, P. M., and R. V. Tauxe.
1991.
The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E. coli, and the associated hemolytic uremic syndrome.
Epidemiol. Rev.
13:60-97[Free Full Text].
|
| 10.
|
Gyles, C.,
R. Johnson,
A. Gao,
K. Ziebell,
D. Pierard,
S. Aleksic, and P. Boerlin.
1998.
Association of enterohemorrhagic Escherichia coli hemolysin with serotypes of Shiga-like-toxin-producing Escherichia coli of human and bovine origins.
Appl. Environ. Microbiol.
64:4134-4141[Abstract/Free Full Text].
|
| 11.
|
Karmali, M. A.
1989.
Infection by verocytotoxin-producing Escherichia coli.
Clin. Microbiol. Rev.
2:15-38[Abstract/Free Full Text].
|
| 12.
|
Louie, M.,
J. C. de Azavedo,
M. Y. C. Handelsman,
C. G. Clark,
B. Ally,
M. Dytoc,
P. Sherman, and J. Brunton.
1993.
Expression and characterization of the eaeA gene product of Escherichia coli serotype O157:H7.
Infect. Immun.
61:4085-4092[Abstract/Free Full Text].
|
| 13.
|
Mainil, J. G.,
E. R. Jacquemin,
A. E. Kaeckenbeeck, and P. H. Pohl.
1993.
Association between the effacing (eae) gene and the Shiga-like toxin-encoding genes in Escherichia coli isolates from cattle.
Am. J. Vet. Res.
54:1064-1068[Medline].
|
| 14.
|
Mujibur Rahaman, M.,
M. Golam Morshed,
K. M. Sultanul Aziz, and M. M. H. Munshi.
1986.
Improved medium for isolating Shigella.
Lancet
i:271-272.
|
| 15.
|
O'Brien, A. D., and R. K. Holmes.
1987.
Shiga and Shiga-like toxins.
Microbiol. Rev.
51:206-220[Free Full Text].
|
| 16.
|
Pierard, D.,
D. Stevens,
L. Moriau,
H. Lior, and S. Lauwers.
1997.
Isolation and virulence factors of verocytotoxin-producing Escherichia coli in human stool samples.
Clin. Microbiol. Infect.
3:531-540[Medline].
|
| 17.
|
Riely, L. W.,
R. S. Remis,
S. D. Helgerson,
H. B. McGee,
J. G. Wells,
B. R. Davis,
R. J. Hebert,
E. S. Olcott,
L. M. Johnson,
N. T. Hargrett,
P. A. Blake, and M. L. Cohen.
1983.
Hemorrhagic colitis associated with a rare Escherichia coli serotype.
N. Engl. J. Med.
308:681-685[Abstract].
|
| 18.
|
Schmidt, H., and H. Karch.
1996.
Enterohemolytic phenotypes and genotypes of Shiga toxin-producing Escherichia coli O111 strains from patients with diarrhea and hemolytic-uremic syndrome.
J. Clin. Microbiol.
34:2364-2367[Abstract].
|
| 19.
|
Schmidt, H.,
B. Plaschke,
S. Franke,
H. Russman,
A. Schwarzkopf,
J. Heesemann, and H. Karch.
1994.
Differentiation in virulence patterns of Escherichia coli possessing eae genes.
Med. Microbiol. Immunol.
183:23-31[Medline].
|
| 20.
|
Scotland, S. M.,
G. A. Willshaw,
H. R. Smith, and B. Rowe.
1987.
Properties of strains of Escherichia coli belonging to serogroup O157 with special reference to production of vero cytotoxins VT1 and VT2.
Epidemiol. Infect.
99:613-624[Medline].
|
| 21.
|
Shimada, T.,
R. Sakazaki,
S. Fujimura,
K. Niwano,
M. Mishina, and K. Takizawa.
1990.
A new selective, differential agar medium for isolation of Vibrio cholerae O1: PMT (polymyxin mannose-tellurite) agar.
Jpn. J. Med. Sci. Biol.
43:37-41[Medline].
|
| 22.
|
Tomás, J. M., and W. W. Kay.
1986.
Tellurite susceptibility and non-plasmid-mediated resistance in Escherichia coli.
Antimicrob. Agents Chemother.
30:127-131[Abstract/Free Full Text].
|
| 23.
|
Walter, E. G., and D. E. Taylor.
1992.
Plasmid-mediated resistance to tellurite: expressed and cryptic.
Plasmid
27:52-64[CrossRef][Medline].
|
| 24.
|
Zadik, P. M.,
P. A. Chapman, and C. A. Siddons.
1993.
Use of tellurite for the selection of verocytotoxigenic Escherichia coli O157.
J. Med. Microbiol.
39:155-158[Abstract].
|
Journal of Clinical Microbiology, April 2000, p. 1684-1687, Vol. 38, No. 4
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Gyles, C. L.
(2007). Shiga toxin-producing Escherichia coli: An overview. J ANIM SCI
85: E45-E62
[Abstract]
[Full Text]
-
Monday, S. R., Keys, C., Hanson, P., Shen, Y., Whittam, T. S., Feng, P.
(2006). Produce Isolates of the Escherichia coli Ont:H52 Serotype That Carry both Shiga Toxin 1 and Stable Toxin Genes. Appl. Environ. Microbiol.
72: 3062-3065
[Abstract]
[Full Text]
-
Blanco, J. E., Blanco, M., Alonso, M. P., Mora, A., Dahbi, G., Coira, M. A., Blanco, J.
(2004). Serotypes, Virulence Genes, and Intimin Types of Shiga Toxin (Verotoxin)-Producing Escherichia coli Isolates from Human Patients: Prevalence in Lugo, Spain, from 1992 through 1999. J. Clin. Microbiol.
42: 311-319
[Abstract]
[Full Text]